Safety testing for vaccines typically leaves much to be desired to begin with, but when it comes to fast-tracked pandemic vaccines, safety testing is accelerated and becomes even more inadequate. It looks like that will be the case with plans underway to fast-track a COVID-19 vaccine to market.
As reported by STAT News, researchers are foregoing some of the normally required safety testing in order to get a genetically engineered coronavirus vaccine out in record time. What’s more, at least one vaccine manufacturer is relying on an entirely novel technique to produce their coronavirus vaccine in partnership with the National Institutes of Health, while by-passing traditional animal testing before conducting human clinical trials. STAT News reports: